1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Effect of genetic profiling on prediction of therapeutic resistance and survival in adult acute myeloid leukemia
    Meeting Abstract

    Walter, R. B.; Othus, M.; Paietta, E. M.; Racevskis, J.; Fernandez, H. F.; Lee, J. W.; Sun, Z. X.; Tallman, M. S.; Patel, J. P.; Gonen, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Glutamine based pet imaging facilitates enhanced metabolic fetection of gliomas in vivo
    Meeting Abstract

    Venneti, S.; Dunphy, M.; Zhang, H. W.; Pitter, K.; Campos, C.; Carlin, S.; Lyashchenko, S.; Ploessl, C.; Rohle, D.; Omuro, A.; more...
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Off-site storage of human cells, tissues, and cellular and tissue-based products
    Meeting Abstract

    Tonon, J.; Tassy, J.; Baxter, M.; Chen, X.; Avecilla, S. T.; Pessin, M.; Meagher, R. C.; Zel, P.; Jakubowski, A. A.; Giralt, S.; more...
    Transfusion (2014)

    Fulltext@MSK | Save
  • Ring expansion approaches to macrocycle and medium ring library synthesis
    Meeting Abstract

    Tan, D. S.
    Abstracts of Papers of the American Chemical Society (2014)

    Fulltext@MSK | Save
  • Allo- HSCT for advanced myelodysplastic syndrome: MSKCC Vs MDACC
    Meeting Abstract

    Tamari, R.; Oran, B.; Hilden, P.; Papadopoulos, E. B.; Kongtim, P.; Rondon, G.; Jakubowski, A. A.; Andersson, B. S.; Devlin, S. M.; Ahmed, S.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • AG-221, an oral, selective, first-in-class, potent inhibitor of the IDH2 mutant metabolic enzyme, induces durable remissions in a phase I study in patients with IDH2 mutation positive advanced hematologic malignancies
    Meeting Abstract

    Stein, E. M.; Altman, J. K.; Collins, R.; DeAngelo, D. J.; Fathi, A. T.; Flinn, I.; Frankel, A.; Levine, R. L.; Medeiros, B. C.; Patel, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Second allogeneic stem cell transplantation for hematologic malignancies using chemotherapy only cytoreduction with clofarabine, melphalan, and thiotepa
    Meeting Abstract

    Spitzer, B.; Perales, M. A.; Kernan, N. A.; Prockop, S. E.; Webb, N.; Castro-Malaspina, H.; Papadopoulos, E. B.; Young, J. W.; Scaradavou, A.; Kobos, R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Characterizing transcriptional and epigenetic signatures induced by FLT3-ITD activation
    Meeting Abstract

    Spitzer, B.; Guryanova, O. A.; Abdel-Wahab, O.; Kucine, N.; Adli, M.; Berman, J. N.; Meshinchi, S.; Bernstein, B.; Pelossof, R.; Leslie, C.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • A systemic xenograft model of Waldenstrom's macroglobulinemia demonstrates the potent anti-tumor effect of second generation CD19 directed chimeric antigen receptor modified T cells in this disease
    Meeting Abstract

    Smith, E. L.; Palomba, M. L.; Park, J. H.; Brentjens, R. J.
    Blood (2014)

    Fulltext@MSK | Save
  • Targeted therapy of B cell lymphoma with a direct inhibitor of the NF-kappa B subunit c-Rel
    Meeting Abstract

    Shono, Y.; Tuckett, A. Z.; Liou, H. C.; Ouk, S.; Doubrovina, E.; Doubrovin, M.; Derenzini, E.; Scallion, M. I.; Tsai, J. J.; Smith, O. M.; more...
    Blood (2014)

    Fulltext@MSK | Save